Nanoparticle-Mediated and Nanoengineered Drug Delivery for Glaucoma: Preclinical Evidence, Early Human Feasibility, and Translational Challenges

Matteo Capobianco, Marco Zeppieri, Maria Letizia Salvetat, Francesco Pellegrini, Alessandra Pizzo, Irene Gattazzo, Fabiana D’Esposito, Francesco Cappellani, Caterina Gagliano

Open source

DOI
10.3390/ph19101544
Published
2026-09-29
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19101544,
  title = {Nanoparticle-Mediated and Nanoengineered Drug Delivery for Glaucoma: Preclinical Evidence, Early Human Feasibility, and Translational Challenges},
  author = {Matteo Capobianco and Marco Zeppieri and Maria Letizia Salvetat and Francesco Pellegrini and Alessandra Pizzo and Irene Gattazzo and Fabiana D’Esposito and Francesco Cappellani and Caterina Gagliano},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19101544},
  url = {https://doi.org/10.3390/ph19101544}
}

RIS

TY  - JOUR
TI  - Nanoparticle-Mediated and Nanoengineered Drug Delivery for Glaucoma: Preclinical Evidence, Early Human Feasibility, and Translational Challenges
AU  - Matteo Capobianco
AU  - Marco Zeppieri
AU  - Maria Letizia Salvetat
AU  - Francesco Pellegrini
AU  - Alessandra Pizzo
AU  - Irene Gattazzo
AU  - Fabiana D’Esposito
AU  - Francesco Cappellani
AU  - Caterina Gagliano
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19101544
UR  - https://doi.org/10.3390/ph19101544
ER  - 

APA

Capobianco, M., Zeppieri, M., Salvetat, M. L., Pellegrini, F., Pizzo, A., Gattazzo, I., D’Esposito, F., Cappellani, F., & Gagliano, C. (2026). Nanoparticle-Mediated and Nanoengineered Drug Delivery for Glaucoma: Preclinical Evidence, Early Human Feasibility, and Translational Challenges. Pharmaceuticals. https://doi.org/10.3390/ph19101544

Source records